Prestige Consumer Healthcare Inc. (PBH)

Market Cap	3.89B
Revenue (ttm)	1.11B
Net Income (ttm)	205.95M
Shares Out	49.41M
EPS (ttm)	4.10
PE Ratio	19.20
Forward PE	16.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,103
Open	78.34
Previous Close	78.66
Day's Range	77.83 - 79.09
52-Week Range	57.95 - 86.36
Beta	0.49
Analysts	Strong Buy
Price Target	83.67 (+6.29%)
Earnings Date	Feb 6, 2025

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Feb 10, 2005
• Employees: 570
• Stock Exchange: NYSE
• Ticker Symbol: PBH
• Website: https://www.prestigebrands.com

Analyst Forecast

According to 3 analysts, the average rating for PBH stock is "Strong Buy." The 12-month stock price forecast is $83.67, which is an increase of 6.29% from the latest price.

Price Target

$83.67

(6.29% upside)

Analyst Consensus: Strong Buy